MedTrace Logo

Effect of Vitamin D Supplement on Disease Activity in SLE

NCT05260255 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-06

No results posted yet for this study

Summary

To study the effect of vitamin D supplementation on disease activity of SLE ( SLEDAI-2K ) and IL-6 level

Conditions

  • Vitamin D Deficiency
  • Hypocalcemia
  • Hyperparathyroidism
  • Systemic Lupus Erythematosus (Disorder)

Interventions

DRUG

vitamin D2 ( calciferol )

add on vitamin D2( calciferol ) 40,000 IU/wk ( 2 cap) for 12 weeks

DRUG

Placebo

add on placebo ( 2 cap ) for 12 weeks

Sponsors & Collaborators

  • Department of Medical Services Ministry of Public Health of Thailand

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2022-05-01
Completion
2022-12-01

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05260255 on ClinicalTrials.gov